hy R&D

Pioneering a sustainable future through continuous innovation from functional probiotics to natural solutions and pet care.

Pioneering a sustainable future through continuous innovation from
functional probiotics to natural solutions and pet care.

Pioneering a sustainable future through continuous innovation from functional probiotics to natural solutions and pet care.

hy R&D Center

hy R&D Center

From the development of Korea’s first Korean-style probiotic strain in 1995
to receiving the ‘Ingredient of the Year’ award at the NutraIngredients USA Awards in 2026,
hy Central Research Institute contributes to healthier lives for humanity
through its accumulated technological expertise and capabilities.

From the development of Korea’s first Korean-style probiotic strain in 1995
to receiving the ‘Ingredient of the Year’ award at the NutraIngredients USA Awards in 2026,
hy Central Research Institute contributes to healthier lives for humanity
through its accumulated technological expertise and capabilities.

From the development of Korea’s first Korean-style probiotic strain in 1995
to receiving the ‘Ingredient of the Year’ award at the NutraIngredients USA Awards in 2026,
hy Central Research Institute contributes to healthier lives for humanity
through its accumulated technological expertise and capabilities.

Introduction

Established in 1976, the hy Central Research Institute is the first corporate-affiliated research center in Korea.

Moving forward, we will continue to lead the microbiome era through relentless innovation and bold challenges, setting new benchmarks in the global healthcare market.

Established in 1976, the hy Central Research Institute is the first corporate-affiliated research center in Korea.

Moving forward, we will continue to lead the microbiome era through relentless innovation and bold challenges, setting new benchmarks in the global healthcare market.

Established in 1976, the hy Central Research Institute is the first corporate-affiliated research center in Korea.

Moving forward, we will continue to lead the microbiome era through relentless innovation and bold challenges, setting new benchmarks in the global healthcare market.

Milestones & Achievements

  1. 1976
    Establishment of the Central Research Institute
  2. 1981
    Certified as an official company-affiliated research institute
  3. 1995
    Developed and commercialized Korea’s first indigenous probiotic strain
  4. 1996
    Certified as a nationally accredited testing laboratory(KOLAS)
  1. 2015
    Registration of HY7714
    (L. plantarum)
    as an individually approved
    functional probiotic ingredient from MFDS
    *MFDS: Ministry of Food and Drug Safety
  2. 2019

    Registration of the probiotic complex containing
    L. curvatus HY7601 and
    L. plantarum KY1032
    as an individually approved functional health ingredient from MFDS

    Registration of the probiotic complex containing
    L. curvatus HY7601 and
    L. plantarum KY1032
    as an individually approved functional health ingredient from MFDS

  3. 2020
    Awarded the Minister’s Prize for R&D Innovation
    (Ministry of Science and ICT)
    Designated as an Excellent Company Research Institute
  4. 2021
    Launched B2B brand hyLabs
    KY1032 registered as a New Dietary Ingredient (NDI)
    with the U.S. FDA
  1. 2022

    HY7601 + KY1032 probiotic
    for body fat reduction wins
    IPC Innovation Award

    HY7601 + KY1032 probiotic
    for body fat reduction wins
    IPC Innovation Award

    Expansion into global markets
  2. 2023
    HY7601 + KY1032 probiotic
    wins the IR52
    Jang Young-Shil Award
  3. 2024

    Functional anti-hangover ingredient, Ice Plant Compound Concentrate,
    receives a commendation from the Ministry of Science and ICT

    Functional anti-hangover ingredient, Ice Plant Compound Concentrate,
    receives a commendation from the Ministry of Science and ICT

    Launched FIAC (Future Insights
    Advisory Committee) for research consultation
    Established industry-academia collaboration with Cornell University (IPP)
  4. 2026

    Designated as an Outstanding Corporate Research Institute

    Designated as an Outstanding Corporate Research Institute

    Probiotics for Body Fat Reduction ‘HY7601+KY1032’

    Probiotics for Body Fat Reduction ‘HY7601+KY1032’

    Skin Lactic Acid Bacteria ‘HY7714’
    NUTRA INGREDIENTS USA Award

Research Areas

  • Discovery and Commercialization of New Functional Ingredients

  • Acquisition of Individually Approved Functional Materials from MFDS

  • Microbiome
    Mechanisms

  • Development of Fermented Dairy Drink, Dietary Supplements, and Conventional Foods

Core Competencies

  • One-Stop Solution

    One-Stop Solution

    We directly manage the entire process
    from strain cultivation to commercialization

    We directly manage the entire process from strain cultivation to commercialization

    We directly manage the entire process
    from strain cultivation to commercialization

  • Expert Research Team

    Expert Research Team

    Dedicated research team of master’s and doctoral-level scientists focused exclusively on developing functional ingredients.

    Dedicated research team of master’s and doctoral-level scientists focused exclusively on developing functional ingredients.

    Dedicated research team of master’s
    and doctoral-level scientists
    focused exclusively on developing
    functional ingredients.

  • State-of-the-Art Research Facilities

    State-of-the-Art Research Facilities

    Our research undergoes in-depth analysis and scientific validation.

    Our research undergoes in-depth analysis and scientific validation.

    Our research undergoes in-depth analysis and scientific validation.